Safety study of ID110521156 in healthy adults
This study tests a new investigational drug called ID110521156 in healthy adults. The goal is to see if the drug is safe and how the body processes it. It may be for people who are overweight or obese.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be in good general health with no major medical conditions.
- You must be between 19 and 50 years old.
- Your BMI must be 27 or higher, and you must weigh at least 50 kg (about 110 lbs).
- Women must not be pregnant or breastfeeding, and must be either postmenopausal or surgically sterile.
- Men who can have children must agree to use effective birth control during the study and for 90 days after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug to see if it is safe and how the body processes it. It is for healthy adults who are willing to participate in a closely monitored clinical trial.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This study tests a new drug called DF5112 in healthy adults to find the safest dose. It helps doctors learn how the drug works in the body before testing it in people with a condition.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
Hear when a new Healthy Adult Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.